메뉴 건너뛰기




Volumn 17, Issue 6, 2002, Pages 1365-1367

Clozapine withdrawal symptoms in a Parkinson's disease patient

Author keywords

Clozapine; Rebound; Serotonin syndrome; Withdrawal

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CLOZAPINE; CYPROHEPTADINE; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; SEROTONIN 2A ANTAGONIST;

EID: 0036869158     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10282     Document Type: Article
Times cited : (20)

References (39)
  • 1
    • 0033549287 scopus 로고    scopus 로고
    • Clozapine in drug-induced psychosis in Parkinson's disease
    • The French Clozapine Parkinson Study Group
    • The French Clozapine Parkinson Study Group. Clozapine in drug-induced psychosis in Parkinson's disease. Lancet 1999;353:2041-2042.
    • (1999) Lancet , vol.353 , pp. 2041-2042
  • 3
    • 0035241276 scopus 로고    scopus 로고
    • Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial
    • Factor SA, Friedman JH, Lannon MC et al. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial. Mov Disord 2001;16:135-139.
    • (2001) Mov. Disord. , vol.16 , pp. 135-139
    • Factor, S.A.1    Friedman, J.H.2    Lannon, M.C.3
  • 4
    • 0030819935 scopus 로고    scopus 로고
    • The emerging role of clozapine in the treatment of movement disorders
    • Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;12:483-496.
    • (1997) Mov. Disord. , vol.12 , pp. 483-496
    • Factor, S.A.1    Friedman, J.H.2
  • 6
    • 0003984765 scopus 로고    scopus 로고
    • 55th Edition. Montvale, NJ: Medical Economics Company
    • Physician's Desk Reference. 55th Edition. Montvale, NJ: Medical Economics Company; 2001. p 2155-2159.
    • (2001) Physician's Desk Reference , pp. 2155-2159
  • 7
    • 0034758931 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome associated with long-term clozapine treatment: Report of a case and results of a clozapine rechallenge
    • Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J 2001;24:522-525.
    • (2001) Chang Gung Med. J. , vol.24 , pp. 522-525
    • Huang, T.L.1
  • 8
    • 0031934775 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome related to use of clozapine
    • Trayer JS, Fidler DC. Neuroleptic malignant syndrome related to use of clozapine. J Am Osteopath Assoc 1998;98:168-169.
    • (1998) J. Am. Osteopath. Assoc. , vol.98 , pp. 168-169
    • Trayer, J.S.1    Fidler, D.C.2
  • 10
    • 0029119464 scopus 로고
    • Clinical implications of clozapine discontinuation: Report of an NIMH workshop
    • Clinical implications of clozapine discontinuation: report of an NIMH workshop. Schizophr Bull 1995;21:333-338.
    • (1995) Schizophr. Bull. , vol.21 , pp. 333-338
  • 11
    • 0032842391 scopus 로고    scopus 로고
    • Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo
    • Tollefson GD, Dellva MA, Mattler CA, et al. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. J Clin Psychopharmacol 1999;19:435-443.
    • (1999) J. Clin. Psychopharmacol. , vol.19 , pp. 435-443
    • Tollefson, G.D.1    Dellva, M.A.2    Mattler, C.A.3
  • 12
    • 0029958232 scopus 로고    scopus 로고
    • Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal
    • Shiovitz TM, Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996;22:591-595.
    • (1996) Schizophr. Bull. , vol.22 , pp. 591-595
    • Shiovitz, T.M.1    Welke, T.L.2    Tigel, P.D.3
  • 14
    • 0030789315 scopus 로고    scopus 로고
    • Clozapine withdrawal resulting in delirium with psychosis: A report of three cases
    • Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997;58:252-255.
    • (1997) J. Clin. Psychiatry , vol.58 , pp. 252-255
    • Stanilla, J.K.1    de Leon, J.2    Simpson, G.M.3
  • 15
    • 0031686299 scopus 로고    scopus 로고
    • Clozapine withdrawal-emergent dystonias and dyskinesias: A case series
    • Ahmed S, Chengappa R, Naidu VR, et al. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998;59:472-477.
    • (1998) J. Clin. Psychiatry , vol.59 , pp. 472-477
    • Ahmed, S.1    Chengappa, R.2    Naidu, V.R.3
  • 16
    • 0029916129 scopus 로고    scopus 로고
    • Relapse following clozapine withdrawal: Effect of cyproheptadine plus neuroleptic
    • Meltzer HY, Lee MA, Ranjan R, et al. Relapse following clozapine withdrawal: effect of cyproheptadine plus neuroleptic. Psychopharmacology 1996;124:176-187.
    • (1996) Psychopharmacology , vol.124 , pp. 176-187
    • Meltzer, H.Y.1    Lee, M.A.2    Ranjan, R.3
  • 19
    • 0030762018 scopus 로고    scopus 로고
    • Clozapine withdrawal: Serotonergic or dopaminergic mechanisms?
    • Meltzer HY. Clozapine withdrawal: serotonergic or dopaminergic mechanisms? Arch Gen Psychiatry 1997;54:760-763.
    • (1997) Arch. Gen. Psychiatry , vol.54 , pp. 760-763
    • Meltzer, H.Y.1
  • 20
    • 0021259918 scopus 로고
    • Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal
    • Ekbom T, Eriksson K, Lindstrom LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 1984;83:293-294.
    • (1984) Psychopharmacology , vol.83 , pp. 293-294
    • Ekbom, T.1    Eriksson, K.2    Lindstrom, L.H.3
  • 21
    • 0021798337 scopus 로고
    • Early relapse after sudden withdrawal or dose reduction of clozapine
    • Perenyi A, Kuncz E, Bagdy G. Early relapse after sudden withdrawal or dose reduction of clozapine. Psychopharmacology 1986;86:244.
    • (1986) Psychopharmacology , vol.86 , pp. 244
    • Perenyi, A.1    Kuncz, E.2    Bagdy, G.3
  • 22
    • 0023143938 scopus 로고
    • Supersensitivity and clozapine withdrawal
    • Eklund K. Supersensitivity and clozapine withdrawal. Psychopharmacology 1987;90:135.
    • (1987) Psychopharmacology , vol.90 , pp. 135
    • Eklund, K.1
  • 23
    • 0026072731 scopus 로고
    • Comparison of withdrawal of typical and atypical antipsychotic drugs: A case study
    • Alphs LK,Lee HS. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study. J Clin Psychiatry 1991;52: 346-348.
    • (1991) J. Clin. Psychiatry , vol.52 , pp. 346-348
    • Alphs, L.K.1    Lee, H.S.2
  • 25
    • 0031919315 scopus 로고    scopus 로고
    • Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience
    • Trosch RM, Friedman JH, Lannon MC, et al. Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord 1998;13:377-382.
    • (1998) Mov. Disord. , vol.13 , pp. 377-382
    • Trosch, R.M.1    Friedman, J.H.2    Lannon, M.C.3
  • 26
    • 0033453264 scopus 로고    scopus 로고
    • Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    • Fernandez HH, Friedman JH, Jacques C, Rosenfeld M. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 1999;14:484-487.
    • (1999) Mov. Disord. , vol.14 , pp. 484-487
    • Fernandez, H.H.1    Friedman, J.H.2    Jacques, C.3    Rosenfeld, M.4
  • 27
    • 0034074975 scopus 로고    scopus 로고
    • Clozapine replacement by Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    • Fernandez HH, Lannon MC, Friedman JH, Abbot BP. Clozapine replacement by Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000;15:579-581.
    • (2000) Mov. Disord. , vol.15 , pp. 579-581
    • Fernandez, H.H.1    Lannon, M.C.2    Friedman, J.H.3    Abbot, B.P.4
  • 28
    • 0016168437 scopus 로고
    • Clozapine: A new antipsychotic agent
    • Simpson GM, Varga E. Clozapine: A new antipsychotic agent. Curr Ther Res 1974;16:679-686.
    • (1974) Curr. Ther. Res. , vol.16 , pp. 679-686
    • Simpson, G.M.1    Varga, E.2
  • 29
    • 33646215977 scopus 로고
    • Clozapine Versus Risperidone in Psychosis
    • Presented at the Annual Meeting of the Society of Biological Psychiatry. Philadelphia, PA, May
    • Daniel DG, Goldberg T, Weinberger DR, et al. Clozapine Versus Risperidone in Psychosis. Presented at the Annual Meeting of the Society of Biological Psychiatry. Philadelphia, PA, May 1994.
    • (1994)
    • Daniel, D.G.1    Goldberg, T.2    Weinberger, D.R.3
  • 31
    • 0028850037 scopus 로고
    • Discontinuing antipsychotic therapy - A practical guide
    • Keks NA, Copolov DL, Burrows GD. Discontinuing antipsychotic therapy - a practical guide. CNS Drugs 1995;4:351-356.
    • (1995) CNS Drugs , vol.4 , pp. 351-356
    • Keks, N.A.1    Copolov, D.L.2    Burrows, G.D.3
  • 32
    • 0018835477 scopus 로고
    • Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacological characteristics
    • Chouinard G, Jones BD. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacological characteristics. Am J Psychiatry 1980;137:16-21.
    • (1980) Am. J. Psychiatry , vol.137 , pp. 16-21
    • Chouinard, G.1    Jones, B.D.2
  • 33
    • 0030023357 scopus 로고    scopus 로고
    • Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics
    • Verghese C, DeLeon J, Nair C, Simpson GM. Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics. Biol Psychiatry 1996;39:135-138.
    • (1996) Biol. Psychiatry , vol.39 , pp. 135-138
    • Verghese, C.1    DeLeon, J.2    Nair, C.3    Simpson, G.M.4
  • 34
    • 0020683905 scopus 로고
    • Antidepressant withdrawal symptoms treated with anticholinergic agents
    • Dilsaver SC, Feinberg M, Greden JF. Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983;140:249-251.
    • (1983) Am. J. Psychiatry , vol.140 , pp. 249-251
    • Dilsaver, S.C.1    Feinberg, M.2    Greden, J.F.3
  • 35
    • 0012334897 scopus 로고
    • Withdrawal symptoms after abrupt termination of imipramine
    • Shatan C. Withdrawal symptoms after abrupt termination of imipramine. Can Psychiatric Association J 1966;2:150-158.
    • (1966) Can. Psychiatric Association J. , vol.2 , pp. 150-158
    • Shatan, C.1
  • 36
    • 0013942220 scopus 로고
    • Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients
    • Greenberg LM, Roth S. Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients. Am J Psychiatry 1966;123:221-226.
    • (1966) Am. J. Psychiatry , vol.123 , pp. 221-226
    • Greenberg, L.M.1    Roth, S.2
  • 37
    • 0012229479 scopus 로고
    • Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic inpatients
    • Melnyk WT, Worthington AG, Laverty SG. Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic inpatients. Am J Psychiatry 1966;11:410-412.35.
    • (1966) Am. J. Psychiatry , vol.11
    • Melnyk, W.T.1    Worthington, A.G.2    Laverty, S.G.3
  • 38
    • 0024429166 scopus 로고
    • Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex
    • Matsubara S, Meltzer HY. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci 1989;45:1397-1406.
    • (1989) Life Sci. , vol.45 , pp. 1397-1406
    • Matsubara, S.1    Meltzer, H.Y.2
  • 39
    • 0027965174 scopus 로고
    • Treatment of the serotonin syndrome with cyproheptadine
    • Lappin RI, Auchincloss EL. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994;331:1021-1022.
    • (1994) N. Engl. J. Med. , vol.331 , pp. 1021-1022
    • Lappin, R.I.1    Auchincloss, E.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.